27/05/2026
10 years. 20+ approved combination products. Nearly 30 therapeutic indications. More than 210 million devices reaching patients globally.
This is what a decade of Molly looks like.
Featured in the latest issue of ONdrugDelivery magazine, Nicholas Heaton, SHL Medical's Global Head of Sales, looks back on the evolution of the Molly autoinjector platform over the past decade and its role in supporting reliable, scalable drug delivery solutions for pharma customers bringing self-injection therapies to patients worldwide.
Read the full interview 👉 https://bit.ly/4fNF9xg